ICD-10 Code C22.0

Liver cell carcinoma

Version 2020 Billable Code Neoplasm Malignant Primary

Valid for Submission

C22.0 is a billable code used to specify a medical diagnosis of liver cell carcinoma. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10 code C22.0 might also be used to specify conditions or terms like adenocarcinoma of liver or combined hepatocellular carcinoma and cholangiocarcinoma or fibrolamellar hepatocellular carcinoma or liver cell carcinoma.

ICD-10:C22.0
Short Description:Liver cell carcinoma
Long Description:Liver cell carcinoma

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C22.0:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Hepatocellular carcinoma
  • Hepatoma

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C22.0 are found in the index:

  • - Embryoma - See Also: Neoplasm, uncertain behavior, by site;

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Adenocarcinoma of liver
  • Combined hepatocellular carcinoma and cholangiocarcinoma
  • Fibrolamellar hepatocellular carcinoma
  • Liver cell carcinoma

Clinical Information

  • CARCINOMA HEPATOCELLULAR-. a primary malignant neoplasm of epithelial liver cells. it ranges from a well differentiated tumor with epithelial cells indistinguishable from normal hepatocytes to a poorly differentiated neoplasm. the cells may be uniform or markedly pleomorphic or form giant cells. several classification schemes have been suggested.

Diagnostic Related Groups

The ICD-10 code C22.0 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 435 - MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC
  • 436 - MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC
  • 437 - MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC

Convert C22.0 to ICD-9

  • 155.0 - Mal neo liver, primary (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of digestive organs (C15-C26)
      • Malignant neoplasm of liver and intrahepatic bile ducts (C22)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C22.0 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

The Tabular must be reviewed for the complete diagnosis code.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»hepatoma
C22.0C78.7D01.5D13.4D37.6D49.0

Information for Patients


Liver Cancer

Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Primary liver cancer starts in the liver. Metastatic liver cancer starts somewhere else and spreads to your liver.

Risk factors for primary liver cancer include

  • Having hepatitis B or C
  • Heavy alcohol use
  • Having cirrhosis, or scarring of the liver
  • Having hemochromatosis, an iron storage disease
  • Obesity and diabetes

Symptoms can include a lump or pain on the right side of your abdomen and yellowing of the skin. However, you may not have symptoms until the cancer is advanced. This makes it harder to treat. Doctors use tests that examine the liver and the blood to diagnose liver cancer. Treatment options include surgery, radiation, chemotherapy, or liver transplantation.

NIH: National Cancer Institute


[Learn More]